MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
UroGen Pharma Ltd. PEG Ratio 2011-2026 | URGN
Annual PEG Ratio UroGen Pharma Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.593 | 0.554 | 0.333 | -0.079 | - | 0.249 | 0.88 | 0.0696 | 0.0502 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.88 | -0.079 | 0.331 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
0.0115 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Coherus BioSciences
CHRS
|
-0.0207 | $ 1.57 | -3.68 % | $ 184 M |  USA |
 |
Happiness Biotech Group Limited
HAPP
|
-0.156 | - | 1.35 % | $ 17.8 M |  China |
 |
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 16.87 | -2.49 % | $ 789 M | USA |
 |
AgeX Therapeutics
AGE
|
0.000009 | - | -10.17 % | $ 12.2 K | USA |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
AstraZeneca PLC
AZN
|
0.103 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 7.47 | -4.6 % | $ 205 M |  Israel |
 |
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.57 | - | 0.74 % | $ 768 M | Israel |
 |
Eton Pharmaceuticals
ETON
|
-0.83 | $ 30.26 | 1.0 % | $ 814 M | USA |
 |
Galera Therapeutics
GRTX
|
0.0195 | - | -32.59 % | $ 7.61 M | USA |
 |
Exelixis
EXEL
|
-2.14 | $ 50.13 | -1.9 % | $ 13.6 B | USA |
 |
Fortress Biotech
FBIO
|
0.00811 | $ 2.41 | 4.78 % | $ 67.2 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.73 | - | -18.52 % | $ 27.3 M | Britain |
|
Forte Biosciences
FBRX
|
-0.00934 | $ 23.11 | -3.55 % | $ 299 M | USA |
 |
AbCellera Biologics
ABCL
|
0.17 | $ 4.09 | -7.05 % | $ 1.22 B | Canada |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.63 | 2.52 % | $ 434 M | Britain |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
BioNTech SE
BNTX
|
0.00586 | $ 89.55 | -2.65 % | $ 21.6 B | Germany |
 |
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | USA |
 |
Galectin Therapeutics
GALT
|
0.235 | $ 2.17 | -7.66 % | $ 139 M | USA |
 |
Celyad Oncology SA
CYAD
|
0.0181 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
0.863 | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
-0.476 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-0.283 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-1.49 | - | - | $ 3.67 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | Israel |
 |
Gilead Sciences
GILD
|
0.24 | $ 129.58 | -1.88 % | $ 161 B | USA |
 |
Advaxis
ADXS
|
-0.00008 | - | -9.65 % | $ 45.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.36 | -3.72 % | $ 5.53 M | Israel |
 |
Aeterna Zentaris
AEZS
|
0.00152 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.0406 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.232 | $ 0.72 | -1.58 % | $ 32.9 M | Israel |
 |
Esperion Therapeutics
ESPR
|
0.799 | $ 3.12 | - | $ 649 M | USA |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | Canada |
 |
Genmab A/S
GMAB
|
0.277 | $ 26.54 | -1.34 % | $ 1.72 B |  Danmark |
 |
Aptinyx
APTX
|
0.00516 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
-0.0646 | - | - | $ 28.6 M | USA |